Paul L. Swiecicki - Search Results

Year	Number of Results
2013	3
2014	1
2015	2
2016	4
2017	3
2018	4
2019	5
2020	9
2021	1

1

Cold agglutinin disease.

Swiecicki PL, Hegerova LT, Gertz MA. Swiecicki PL, et al. Blood. 2013 Aug 15;122(7):1114-21. doi: 10.1182/blood-2013-02-474437. Epub 2013 Jun 11. Blood. 2013. PMID: 23757733 Review.

2

Head and Neck Squamous Cell Carcinoma Detection and Surveillance: Advances of Liquid Biomarkers.

Swiecicki PL, Brennan JR, Mierzwa M, Spector ME, Brenner JC. Swiecicki PL, et al. Laryngoscope. 2019 Aug;129(8):1836-1843. doi: 10.1002/lary.27725. Epub 2018 Dec 20. Laryngoscope. 2019. PMID: 30570748 Free PMC article. Review.

3

Targeted Therapy and Traditional Chemotherapy in Melanoma and Cutaneous Squamous Cell Carcinoma.

Ma VT, Haring CT, Warrier G, Swiecicki PL. Ma VT, et al. Among authors: swiecicki pl. Facial Plast Surg. 2020 Apr;36(2):186-193. doi: 10.1055/s-0040-1709126. Epub 2020 May 15. Facial Plast Surg. 2020. PMID: 32413927 Review.

4

Functional outcomes and tracheostomy dependence following salvage oropharyngeal surgery.

Heft Neal ME, Gao RW, Brennan JR, Haring CT, Chinn SB, Shuman AG, Casper KA, Malloy KM, Stucken CL, Mclean SA, Chad Brenner J, Lyden T, Blakely A, Mierzwa ML, Shah J, Schonewolf C, Swiecicki PL, Worden FP, Wolf GT, Bradford CR, Prince MEP, Rosko AJ, Spector ME. Heft Neal ME, et al. Among authors: swiecicki pl. Oral Oncol. 2020 Oct 8:105034. doi: 10.1016/j.oraloncology.2020.105034. Online ahead of print. Oral Oncol. 2020. PMID: 33041214 No abstract available.

5

Window of opportunity trials in head and neck cancer.

Farlow JL, Birkeland AC, Swiecicki PL, Brenner JC, Spector ME. Farlow JL, et al. Among authors: swiecicki pl. J Cancer Metastasis Treat. 2019;5:18. doi: 10.20517/2394-4722.2018.100. Epub 2019 Mar 18. J Cancer Metastasis Treat. 2019. PMID: 31321307 Free PMC article.

6

Axitinib in the Treatment of Head and Neck Malignancies.

Swiecicki PL, Spector M, Worden FP. Swiecicki PL, et al. Curr Clin Pharmacol. 2016;11(2):72-6. doi: 10.2174/1574884711666160518120622. Curr Clin Pharmacol. 2016. PMID: 27188575 Review.

7

Patient-reported financial toxicity and adverse medical consequences in head and neck cancer.

Beeler WH, Bellile EL, Casper KA, Jaworski E, Burger NJ, Malloy KM, Spector ME, Shuman AG, Rosko A, Stucken CL, Chinn SB, Dragovic AF, Chapman CH, Owen D, Jolly S, Bradford CR, Prince MEP, Worden FP, Jagsi R, Mierzwa ML, Swiecicki PL. Beeler WH, et al. Among authors: swiecicki pl. Oral Oncol. 2020 Feb;101:104521. doi: 10.1016/j.oraloncology.2019.104521. Epub 2019 Dec 23. Oral Oncol. 2020. PMID: 31877502

8

Prognostic Significance of Oxidation Pathway Mutations in Recurrent Laryngeal Squamous Cell Carcinoma.

Heft Neal ME, Bhangale AD, Birkeland AC, McHugh JB, Shuman AG, Rosko AJ, Swiecicki PL, Spector ME, Brenner JC. Heft Neal ME, et al. Among authors: swiecicki pl. Cancers (Basel). 2020 Oct 22;12(11):3081. doi: 10.3390/cancers12113081. Cancers (Basel). 2020. PMID: 33105726 Free PMC article.

9

Efficacy of axitinib in metastatic head and neck cancer with novel radiographic response criteria.

Swiecicki PL, Bellile EL, Brummel CV, Brenner JC, Worden FP. Swiecicki PL, et al. Cancer. 2021 Jan 15;127(2):219-228. doi: 10.1002/cncr.33226. Epub 2020 Oct 20. Cancer. 2021. PMID: 33079405

10

Role of Treatment Deintensification in the Management of p16+ Oropharyngeal Cancer: ASCO Provisional Clinical Opinion.

Adelstein DJ, Ismaila N, Ku JA, Burtness B, Swiecicki PL, Mell L, Beitler JJ, Gross N, Jones CU, Kaufman M, Le QT, Semrad TJ, Siu LL, Ridge JA. Adelstein DJ, et al. Among authors: swiecicki pl. J Clin Oncol. 2019 Jun 20;37(18):1578-1589. doi: 10.1200/JCO.19.00441. Epub 2019 Apr 25. J Clin Oncol. 2019. PMID: 31021656

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results